Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $46.5 million versus the consensus estimate of $44.48 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.